Global Bioabsorbable Stents Market Value Expected To Reach $408 Million By 2023

Global Bioabsorbable Stents Market Value Expected To Reach $408 Million By 2023

“Bioabsorbable Stents Market Global Report 2020-30: Covid 19 Growth And Change”
Arterius Is One Of The Largest Players In The Bioabsorbable Stents Market, According To The Business Research Company’s Bioabsorbable Stents Market Global Report 2020-30: COVID-19 Growth and Change. (Companies Covered: Abbott Laboratories, REVA Medical, Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical, Tepha, Inc., S3V Vascular Technologies, ICON Interventional Systems, Arterius Limited.)

The global bioabsorbable stents market is expected to decline from $296.9 million in 2019 to $294.75 million in 2020 at a rate of -0.73%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The outbreak also restricted or postponed the non-emergency treatments for cardiovascular diseases impacting the market revenue. The market is then expected to recover and reach $408.92 million in 2023 at a rate of 11.53%.

Read More On The Global Bioabsorbable Stents Market Report At –

Bioabsorbable stents, also known as bioresorbable stents (BRS) or vascular scaffolds are coronary stents that can fully dissolve in the body. These biodegradable stents are used in percutaneous coronary intervention (PCI) procedures for providing structural support to the treated vessels and prevent acute recoil & restenosis. Bioabsorbable stents are commonly used in the treatment of heart diseases.

Global Bioabsorbable Stents Market Segmentation –
The bioabsorbable stents market covered in this report is segmented
1. By Product Type: Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents
2. By Absorption Rate: Slow-absorption stents, Fast- absorption stents
3. By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Global Bioabsorbable Stents Market Drivers –

Cardiovascular disorders are the leading cause of death across the world and 4 out of 5 cardiovascular deaths are caused by strokes and heart attacks. Moreover, one-third of such deaths occur prematurely in people under the age of 70. Bioresorbable stents are built primarily to reduce these risks of late complications, such as scaffold thrombosis or restenosis, that can happen when a conventional metal stent’s rigid metal backbone remains permanently rooted in the diseased vessel.

Request For A Sample Of The Global Bioabsorbable Stents Market Report At –

A Few Points From The Global Bioabsorbable Stents Market ToC
1. Executive Summary
2. Bioabsorbable Stents Market Characteristics
3. Bioabsorbable Stents Market Size And Growth
3.1. Global Bioabsorbable Stents Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Bioabsorbable Stents Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Bioabsorbable Stents Market Segmentation
5. Bioabsorbable Stents Market Regional And Country Analysis
5.1. Global Bioabsorbable Stents Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Bioabsorbable Stents Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Media Contact
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
City: London
State: Greater London
Country: United Kingdom